InvestorsHub Logo
Followers 248
Posts 11340
Boards Moderated 0
Alias Born 06/22/2006

Re: goodfela58 post# 1408

Wednesday, 01/08/2020 3:38:02 PM

Wednesday, January 08, 2020 3:38:02 PM

Post# of 3664

“This acquisition will propel us into a solid position of leadership in CBD product formulation standardization and quality assurance of hemp-based medicinal CBD products,” said Frank Igwealor, Cannabionoid Biosciences’ CFO. “With our vision of building a completely vertically integrated CBD operation model, ensuring quality and premium status of product in our distribution is paramount.“ This acquisitions will also be accretive to our earnings immediately as follows:

Total Acquisition Cost: $33,430,000
Fixed Assets Acquired: $18,850,000
Total Projected Revenue: $30,257,162
Estimated Net Profit: $9,322,460

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GMPW News